Skip to Main Content

Paper Details

Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α.
Clin Cancer Res
16
2020
Anastrozole, CYP19A1, EBCE, ER, Early Breast Cancer, Estrogen, Estrogen Receptor, Women, anastrozole, aromatase, aromatase-deficient CYP19A1 T47D breast cancer cell line, breast cancer, cancer, element, estradiol, estrogen, estrogen receptor, estrone, exemestane, letrozole, luciferase
Author NameAffiliation
James N IngleMayo Clinic
Vera J SumanMayo Clinic
Lois Shepherd
Peter A FaschingComprehensive Cancer Center Erlangen-EMN, University Hospital
Tanya L HoskinMayo Clinic
Matthew J EllisBaylor University College of Medicine
Matthew P GoetzMayo Clinic
Cristina CorreiaMayo Clinic
Scott H KaufmannMayo Clinic
Scott H KaufmannMayo Clinic
Scott H KaufmannMayo Clinic
Scott H KaufmannMayo Clinic
Richard M WeinshilboumMayo Clinic
Liewei WangMayo Clinic
  • 1 - 14

Datasets

Release 1.2